BioSpace News Archive

Neurodiagnostic and Monitoring Devices Market in the US 2018-2022| Key Insights and Forecasts| Technavio

Market research firm Technavio has announced the release of their latest report on the neurodiagnostic and monitoring devices market in the US.

June 8, 2018
·
4 min read
Khiron to Open TSX Venture Exchange and Host Media Interviews on June 11, 2018

Khiron life Sciences Corp. will open the market of the TSX Venture Exchange on Monday, June 11, 2018 at 9:30 a.m. EDT.

June 8, 2018
·
3 min read
Business

Phil Yang Biological Technology Co., Ltd. and SCIENFOOD Announced the Layout of the Asian Market, China’s Big Health Market Pattern will be Rewritten

SCIENFOOD is recognized and sought after by American authoritative organizations and consumers.

June 8, 2018
·
1 min read
Business

EyeSouth Establishes a Presence in South Georgia and North Florida Through a Strategic Partnership with South Georgia / North Florida Eye Partners

EyeSouth is an eye care-focused physician services organization formed by Shore Capital Partners, a leading lower middle market healthcare private equity firm.

June 8, 2018
·
4 min read
Business

Autolus Announces Appointment of Andrew J. Oakley as Senior Vice President and Chief Financial Officer

Effective prior to the closing of Autolus’ planned initial public offering.

June 8, 2018
·
2 min read
Job Trends

Benchmark Electronics Announces Quarterly Cash Dividend

- Second quarter 2018 cash dividend of $0.15 per share

June 8, 2018
·
2 min read
Job Trends

Healthcare Trust of America, Inc. Announces Stock Repurchase Program

Board of Directors approved a stock repurchase program authorizing the Company to purchase up to $100 million of its Class A common stock from time to time prior to June 7, 2020.

June 8, 2018
·
5 min read
Drug Development

Alnylam Reports Updated Positive Results from Phase 1/2 Study of Lumasiran in Patients with Primary Hyperoxaluria Type 1 (PH1)

Patients Receiving Investigational Lumasiran Experienced Substantial and Sustained Reductions in Urinary Oxalate, Confirming Potential for RNAi-Mediated Inhibition of Glycolate Oxidase as a Robust Therapeutic Approach for PH1

June 8, 2018
·
11 min read
Biotech Bay

BioTime Announces Submission of Draft Registration Statement for a Proposed Distribution of Its AgeX Shares

Draft registration statement filed on Form 10 with the U.S. Securities and Exchange Commission

June 8, 2018
·
5 min read
Deals

Magenta Therapeutics Launches Proposed Initial Public Offering

Magenta Therapeutics is a clinical-stage biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients

June 8, 2018
·
4 min read